Risk Factors Associated With Morbidity and Mortality in Emergency Colorectal Cancer Resections
1 other identifier
observational
191
1 country
1
Brief Summary
Study is designed to investigate the risk factors associated with morbidity and mortality in patients who underwent emergency resection because of colorectal cancer in general surgery clinic of a tertiary referral hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2023
CompletedFirst Submitted
Initial submission to the registry
September 29, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedOctober 10, 2023
October 1, 2023
16 days
September 29, 2023
October 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Morbidity
Patients developed a major complication that has a Clavien-Dindo Score ≥3
Until postoperative 90 days
Mortality
Patients died in the postoperative period within 90 days
Until postoperative 90 days
Study Arms (1)
Emergency Colorectal Cancer Resection
Patients that underwent emergent resection because of histopathologically confirmed colorectal carcinoma
Interventions
Patients underwent resection due to colorectal carcinoma in emergency surgery
Eligibility Criteria
Patients who underwent emergency colorectal resection between January 2019 and December 2022
You may qualify if:
- Patients who underwent emergency colorectal resection between January,1 2019 and December,31 2022 were included. All patients were equal or older than 18 years and histopathologically found to have primary colorectal malignant neoplasms
You may not qualify if:
- Patients operated with a different indication from primary colorectal cancer such as diverticulitis, ischemia, inflammatory bowel diseases or metastases of another malignancy
- Patients with insufficient clinical data were also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bakırkoy Dr.Sadi Konuk Training and Research Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mehmet Karabulut
University of Health Sciences, Bakirkoy Dr.Sadi Konuk Training and Research
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 29, 2023
First Posted
October 10, 2023
Study Start
July 25, 2023
Primary Completion
August 10, 2023
Study Completion
August 30, 2023
Last Updated
October 10, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share